November 23, 2024
The Supreme Court agreed to weight appeals from the Biden administration and drug manufacturer Danco regarding FDA approvals of the abortion mifepristone pill.

The Supreme Court decided on Wednesday to hear a case on access to the abortion bill and its approval process, which has been defended by the Biden administration. 

The nation’s highest court agreed to consider appeals from the Biden administration and drug manufacturer Danco defending several moves by the U.S. Food and Drug Administration intended to make it easier to access and use the mifepristone pill in the wake of the overturning of Roe v. Wade last year.

This is a breaking news story. Check back for updates.